Biotechnology Industry












ASSOCHAM: Biotech sector to touch US$ 5 bn by 2009-10

According to ASSOCHAM, with a consecutive CAGR of 35.1%, the Biotech sector is expected to grow to US$ 5 billion by 2009-10. Accounting
for 52% of the industry's total revenue, Biotech sector exports are valued at US$ 763 million. With a growth rate of 36%, the investments in the sector have grown to US$ 360 million in 2005-06. Currently, there are more than 300 biotech companies focusing on different aspects of value chain and this figure is expected to double in the next 3-4 years.

With a growth rate of 32%, Biopharma sector has grown to US$ 1 billion in 2005-06. It accounts for over 70% of domestic sales and 75% of total exports. Agri Biotech and BioServices are registering fastest growth and Vaccines and
Bio-Generics are the common areas of interest for the leading biotech companies. In coming 3-4 years, apart from the knowledge-based industry, a series of
joint ventures will come up in application of biotechnology in horticulture, agriculture and viticulture. The sector has the potential to attract funding from international bodies like World Bank, International Finance Corporations, Ventures Capitals and Private Equity Arms.